$IART
Integra Lifesciences Holdings Corp Stock $iart

$iart Overview Financials Valuation SEC Filings Company Website

2019 Q1 Form 10-Q Financial Statement

#000091752019000021 Filed on April 29, 2019

Income Statement

Concept	2019 Q1	2018 Q1
Revenue	$359.7M	$357.1M
YoY Change	0.73%	38.06%
Cost Of Revenue	$128.9M	$144.2M
YoY Change	-10.62%	66.57%
Gross Profit	$230.8M	$212.9M
YoY Change	8.42%	23.72%
Gross Profit Margin	64.16%	59.61%
Selling, General & Admin	$174.9M	$163.6M
YoY Change	6.91%	14.79%
% of Gross Profit	75.77%	76.84%
Research & Development	$18.32M	$18.33M
YoY Change	-0.02%	18.27%
% of Gross Profit	7.94%	8.61%
Depreciation & Amortization	$27.09M	$27.10M
YoY Change	-0.01%	37.42%
% of Gross Profit	11.74%	12.73%
Operating Expenses	$193.2M	$181.9M
YoY Change	6.21%	15.13%
Operating Profit	$32.31M	$25.58M
YoY Change	26.31%	156.84%
Interest Expense	$13.15M	$18.77M
YoY Change	-29.94%	265.78%
% of Operating Profit	40.7%	73.37%
Other Income/Expense, Net	$3.236M	$2.245M
YoY Change	44.14%	-2594.44%
Pretax Income	$24.82M	$9.132M
YoY Change	171.82%	92.46%
Income Tax	-$7.933M	-$1.860M
% Of Pretax Income	-31.96%	-20.37%
Net Earnings	$32.76M	$10.99M
YoY Change	198.0%	71.91%
Net Earnings / Revenue	9.11%	3.08%
Basic Earnings Per Share	$0.38	$0.14
Diluted Earnings Per Share	$0.38	$0.14
COMMON SHARES
Basic Shares Outstanding	85.34M shares	78.55M shares
Diluted Shares Outstanding	86.26M shares	79.83M shares

Balance Sheet

Concept	2019 Q1	2018 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$157.0M	$189.4M
YoY Change	-17.11%	39.88%
Cash & Equivalents	$157.0M	$189.4M
Short-Term Investments
Other Short-Term Assets	$99.60M	$96.50M
YoY Change	3.21%	171.83%
Inventory	$287.0M	$290.5M
Prepaid Expenses
Receivables	$279.1M	$272.3M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$822.7M	$848.7M
YoY Change	-3.06%	49.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$306.4M	$274.0M
YoY Change	11.79%	19.61%
Goodwill	$922.5M	$944.5M
YoY Change	-2.33%	63.34%
Intangibles	$1.059B	$1.148B
YoY Change	-7.78%	75.42%
Long-Term Investments
YoY Change
Other Assets	$79.13M	$26.10M
YoY Change	203.18%	92.03%
Total Long-Term Assets	$2.383B	$2.399B
YoY Change	-0.67%	62.09%
TOTAL ASSETS
Total Short-Term Assets	$822.7M	$848.7M
Total Long-Term Assets	$2.383B	$2.399B
Total Assets	$3.206B	$3.248B
YoY Change	-1.29%	58.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$100.6M	$87.00M
YoY Change	15.63%	90.79%
Accrued Expenses	$92.49M	$107.8M
YoY Change	-14.22%	132.6%
Deferred Revenue	$3.750M	$3.600M
YoY Change	4.17%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$33.80M	$60.00M
YoY Change	-43.67%	852.38%
Total Short-Term Liabilities	$288.1M	$336.0M
YoY Change	-14.26%	78.66%
LONG-TERM LIABILITIES
Long-Term Debt	$1.331B	$1.772B
YoY Change	-24.89%	108.77%
Other Long-Term Liabilities	$131.9M	$68.33M
YoY Change	93.03%	136.79%
Total Long-Term Liabilities	$131.9M	$68.33M
YoY Change	93.03%	136.79%
TOTAL LIABILITIES
Total Short-Term Liabilities	$288.1M	$336.0M
Total Long-Term Liabilities	$131.9M	$68.33M
Total Liabilities	$1.809B	$2.249B
YoY Change	-19.59%	87.98%
SHAREHOLDERS EQUITY
Retained Earnings	$381.1M	$297.5M
YoY Change	28.11%	31.15%
Common Stock	$1.193B	$823.3M
YoY Change	44.86%	2.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$120.1M	$120.7M
YoY Change	-0.52%	-1.88%
Treasury Stock Shares	2.869M shares	2.890M shares
Shareholders Equity	$1.397B	$998.4M
YoY Change
Total Liabilities & Shareholders Equity	$3.206B	$3.248B
YoY Change	-1.29%	58.5%

Cashflow Statement

Concept	2019 Q1	2018 Q1
OPERATING ACTIVITIES
Net Income	$32.76M	$10.99M
YoY Change	198.0%	71.91%
Depreciation, Depletion And Amortization	$27.09M	$27.10M
YoY Change	-0.01%	37.42%
Cash From Operating Activities	$29.48M	$41.53M
YoY Change	-29.01%	43.8%
INVESTING ACTIVITIES
Capital Expenditures	$16.09M	$15.39M
YoY Change	4.54%	67.41%
Acquisitions
YoY Change
Other Investing Activities	$300.0K	$6.100M
YoY Change	-95.08%	-103.32%
Cash From Investing Activities	-$15.81M	-$9.298M
YoY Change	69.99%	-95.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$5.393M	-$20.89M
YoY Change	-125.82%	-111.29%
NET CHANGE
Cash From Operating Activities	$29.48M	$41.53M
Cash From Investing Activities	-$15.81M	-$9.298M
Cash From Financing Activities	$5.393M	-$20.89M
Net Change In Cash	$18.19M	$14.46M
YoY Change	25.77%	-30.4%
FREE CASH FLOW
Cash From Operating Activities	$29.48M	$41.53M
Capital Expenditures	$16.09M	$15.39M
Free Cash Flow	$13.40M	$26.14M
YoY Change	-48.75%	32.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2019Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	61711000	USD
CY2019Q1	dei	Amendment Flag AmendmentFlag	false
CY2019Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2019Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2019Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2019
CY2019Q1	dei	Document Period End Date DocumentPeriodEndDate	2019-03-31
CY2019Q1	dei	Document Type DocumentType	10-Q
CY2019Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000917520
CY2019Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	85476801	shares
CY2019Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2019Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2019Q1	dei	Entity Registrant Name EntityRegistrantName	INTEGRA LIFESCIENCES HOLDINGS CORP
CY2019Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2019Q1	dei	Trading Symbol TradingSymbol	iart
CY2019Q1	iart	Contract With Customer Asset Net Of Reclassified To Receivable ContractWithCustomerAssetNetOfReclassifiedToReceivable	5848000	USD
CY2019Q1	iart	Contract With Customer Liability Increase From Foreign Currency Translation ContractWithCustomerLiabilityIncreaseFromForeignCurrencyTranslation	4000	USD
CY2019Q1	iart	Contract With Customer Liability Net Of Revenue Recognized And Foreign Currency Translation ContractWithCustomerLiabilityNetOfRevenueRecognizedAndForeignCurrencyTranslation	800000	USD
CY2018Q4	iart	Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill	1398921000	USD
CY2019Q1	iart	Cost Of Definite And Indefinite Lived Intangible Assets Gross Excluding Goodwill CostOfDefiniteAndIndefiniteLivedIntangibleAssetsGrossExcludingGoodwill	1394272000	USD
CY2018Q4	iart	Debt Accounts Receivable Securitization Term DebtAccountsReceivableSecuritizationTerm	P3Y
CY2019Q1	iart	Debt Weighted Average Interest Rate From Securitization DebtWeightedAverageInterestRateFromSecuritization	0.035
CY2018Q4	iart	Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill	1079496000	USD
CY2019Q1	iart	Definite And Indefinite Lived Intangible Assets Net Excluding Goodwill DefiniteAndIndefiniteLivedIntangibleAssetsNetExcludingGoodwill	1058630000	USD
CY2019Q1	iart	Finite Lived Intangible Assets Amortization Expense After Year Six FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearSix	535900000	USD
CY2019Q1	iart	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	59500000	USD
CY2019Q1	iart	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	1	renewal_option
CY2018Q1	iart	Paymentfor Contingent Consideration Liability Net Miscellaneous Acquisition Expenses Financing Activities PaymentforContingentConsiderationLiabilityNetMiscellaneousAcquisitionExpensesFinancingActivities	7772000	USD
CY2019Q1	iart	Paymentfor Contingent Consideration Liability Net Miscellaneous Acquisition Expenses Financing Activities PaymentforContingentConsiderationLiabilityNetMiscellaneousAcquisitionExpensesFinancingActivities	0	USD
CY2019Q1	iart	Return Policy Issueof Credit Numberof Daysfrom Shipment ReturnPolicyIssueofCreditNumberofDaysfromShipment	P90D
CY2019Q1	iart	Revenue Product Warranty Period RevenueProductWarrantyPeriod	P2Y
CY2018Q4	iart	Secured Longterm Debt Securitization Program Noncurrent SecuredLongtermDebtSecuritizationProgramNoncurrent	121200000	USD
CY2019Q1	iart	Secured Longterm Debt Securitization Program Noncurrent SecuredLongtermDebtSecuritizationProgramNoncurrent	126000000	USD
CY2019Q1	iart	Secured Longterm Debt Securitization Program Noncurrent SecuredLongtermDebtSecuritizationProgramNoncurrent	126000000	USD
CY2019Q1	iart	Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans	2	plan
CY2018Q4	iart	Transferors Interests In Transferred Financial Assets Maximum Investment Limit TransferorsInterestsInTransferredFinancialAssetsMaximumInvestmentLimit	150000000.0	USD
CY2018Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	76050000	USD
CY2019Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	100553000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	265737000	USD
CY2019Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	279072000	USD
CY2018Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	84545000	USD
CY2019Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	92492000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-45443000	USD
CY2019Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-56679000	USD
CY2018Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1192601000	USD
CY2019Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1191807000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4745000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	4119000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3719000	USD
CY2019Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4099000	USD
CY2018Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1519000	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1357000	USD
CY2018Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5390000	USD
CY2019Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5279000	USD
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	200000	shares
CY2019Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	300000	shares
CY2018Q4	us-gaap	Assets Assets	3107887000	USD
CY2019Q1	us-gaap	Assets Assets	3205711000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	775082000	USD
CY2019Q1	us-gaap	Assets Current AssetsCurrent	822686000	USD
CY2018Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	379000	USD
CY2019Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	194000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	0	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138838000	USD
CY2019Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	157025000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	174935000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	189396000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	138838000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	157025000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	14461000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18187000	USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000	shares
CY2019Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	240000000	shares
CY2018Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88044000	shares
CY2019Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	88304000	shares
CY2018Q4	us-gaap	Common Stock Value CommonStockValue	880000	USD
CY2019Q1	us-gaap	Common Stock Value CommonStockValue	882000	USD
CY2019Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6843000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	57778000	USD
CY2019Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	57660000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	32604000	USD
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21520000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	4193000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	5848000	USD
CY2019Q1	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	4193000	USD
CY2018Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12716000	USD
CY2019Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	12355000	USD
CY2018Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3764000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3800000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3750000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	8600000	USD
CY2019Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	1165000	USD
CY2018Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	144222000	USD
CY2019Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	128912000	USD
CY2018Q1	us-gaap	Costs And Expenses CostsAndExpenses	331503000	USD
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	327382000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6805000	USD
CY2019Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	16404000	USD
CY2018Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1636000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	0	USD
CY2018Q4	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Next Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear	1900000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear	1900000	USD
CY2018Q4	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	31100000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Fair Value Of Plan Assets DefinedBenefitPlanFairValueOfPlanAssets	30100000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	600000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Net Periodic Benefit Cost DefinedBenefitPlanNetPeriodicBenefitCost	500000	USD
CY2018Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	700000	USD
CY2019Q1	us-gaap	Defined Benefit Plan Service Cost DefinedBenefitPlanServiceCost	700000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27096000	USD
CY2019Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	27093000	USD
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.14
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.14
CY2018Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	3114000	USD
CY2019Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-884000	USD
CY2018Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.204
CY2019Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.320
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	75693000	USD
CY2019Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	57561000	USD
CY2018Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-6776000	USD
CY2019Q1	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	-6157000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	319425000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	335642000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	49500000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	60300000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	61200000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	64700000	USD
CY2019Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	65800000	USD
CY2018Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-146000	USD
CY2019Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-367000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	926475000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	922508000	USD
CY2019Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-3967000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	9132000	USD
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	24823000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1860000	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7933000	USD
CY2019Q1	us-gaap	Income Tax Holiday Income Tax Benefits Per Share IncomeTaxHolidayIncomeTaxBenefitsPerShare	0.13
CY2019Q1	us-gaap	Income Tax Reconciliation Tax Holidays IncomeTaxReconciliationTaxHolidays	-10800000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2974000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5387000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	18400000	USD
CY2019Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13705000	USD
CY2018Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	0	USD
CY2019Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-188000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1297000	USD
CY2019Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12048000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-69000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	4608000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-339000	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	628000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-12163000	USD
CY2019Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	12949000	USD
CY2018Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1282000	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	915000	shares
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1079496000	USD
CY2019Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1058630000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	18768000	USD
CY2019Q1	us-gaap	Interest Expense InterestExpense	13149000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	179885000	USD
CY2019Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	178263000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	280347000	USD
CY2019Q1	us-gaap	Inventory Net InventoryNet	286962000	USD
CY2018Q4	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	52747000	USD
CY2019Q1	us-gaap	Inventory Raw Materials And Purchased Parts Net Of Reserves InventoryRawMaterialsAndPurchasedPartsNetOfReserves	56059000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	47715000	USD
CY2019Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	52640000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	76000	USD
CY2019Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	2428000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	96041000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	42617000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	7578000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	9450000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	11828000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	12705000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	11863000	USD
CY2019Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	21711000	USD
CY2018Q4	us-gaap	Liabilities Liabilities	1732091000	USD
CY2019Q1	us-gaap	Liabilities Liabilities	1808681000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3107887000	USD
CY2019Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3205711000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	262552000	USD
CY2019Q1	us-gaap	Liabilities Current LiabilitiesCurrent	288106000	USD
CY2018Q2	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	2200000000.0	USD
CY2019Q1	us-gaap	Long Term Debt LongTermDebt	900000000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	708750000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	67500000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	56250000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	45000000	USD
CY2019Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	22500000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-20886000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5393000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-9298000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15806000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41531000	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	29484000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	10992000	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	32756000	USD
CY2019Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	Segment
CY2019Q1	us-gaap	Oci Before Reclassifications Net Of Tax Attributable To Parent OciBeforeReclassificationsNetOfTaxAttributableToParent	-4484000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	25579000	USD
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	32308000	USD
CY2018Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	3400000	USD
CY2019Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	4400000	USD
CY2019Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	74330000	USD
CY2019Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	12619000	USD
CY2019Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	64999000	USD
CY2019Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3408000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-4236000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	21612000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-11236000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	169702000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	16768000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	11003000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	13233000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	12493000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	13806000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	102399000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	16300000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	19917000	USD
CY2019Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	79133000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	6000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent	-9000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	13780000	USD
CY2019Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-7009000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	7838000	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	80048000	USD
CY2019Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	131890000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2245000	USD
CY2019Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3236000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15387000	USD
CY2019Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	16086000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2019Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2019Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	90160000	USD
CY2019Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	99627000	USD
CY2018Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	221000	USD
CY2019Q1	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	245000	USD
CY2018Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	25000000	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	67200000	USD
CY2018Q1	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	5720000	USD
CY2019Q1	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	148000	USD
CY2019Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	35000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3662000	USD
CY2019Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1750000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	300112000	USD
CY2019Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	306350000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	1375796000	USD
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	1397030000	USD
CY2019Q1	us-gaap	Reclassification From Aoci Current Period Net Of Tax Attributable To Parent ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent	6752000	USD
CY2018Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	35000000	USD
CY2019Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	57400000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18325000	USD
CY2019Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	18321000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	348373000	USD
CY2019Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	381129000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	357082000	USD
CY2019Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	359690000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	3000000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2900000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2200000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1300000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	800000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	2200000	USD
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P9M
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
CY2019Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2004000	USD
CY2018Q4	us-gaap	Secured Debt Current SecuredDebtCurrent	22500000	USD
CY2019Q1	us-gaap	Secured Debt Current SecuredDebtCurrent	33750000	USD
CY2018Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1210513000	USD
CY2019Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	1205025000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	163566000	USD
CY2019Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	174870000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4731000	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	4083000	USD
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	202752	shares
CY2019Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.74
CY2018Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	553000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	716000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3110000	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-6732000	USD
CY2019Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-5121000	USD
CY2018Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	USD
CY2018Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	225000000	USD
CY2019Q1	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	225000000	USD
CY2018Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2019Q1	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0	shares
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	962306000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	998440000	USD
CY2018	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	41.87
CY2019Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	41.87
CY2018Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2900000	shares
CY2019Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	2900000	shares
CY2018Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	120600000	USD
CY2019Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	120100000	USD
CY2018Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2881000	shares
CY2019Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	2869000	shares
CY2018Q4	us-gaap	Treasury Stock Value TreasuryStockValue	120615000	USD
CY2019Q1	us-gaap	Treasury Stock Value TreasuryStockValue	120109000	USD
CY2018Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	79834000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	86258000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78552000	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	85343000	shares
CY2018Q2	us-gaap	Write Off Of Deferred Debt Issuance Cost WriteOffOfDeferredDebtIssuanceCost	800000	USD

Files In Submission

Name	View Source	Status
0000917520-19-000021-index-headers.html	Edgar Link	pending
0000917520-19-000021-index.html	Edgar Link	pending
0000917520-19-000021.txt	Edgar Link	pending
0000917520-19-000021-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
iart-20190331.xml	Edgar Link	completed
iart-20190331.xsd	Edgar Link	pending
iart-2019033110xq.htm	Edgar Link	pending
iart-20190331xexx311.htm	Edgar Link	pending
iart-20190331xexx312.htm	Edgar Link	pending
iart-20190331xexx321.htm	Edgar Link	pending
iart-20190331xexx322.htm	Edgar Link	pending
iart-20190331_cal.xml	Edgar Link	unprocessable
iart-20190331_def.xml	Edgar Link	unprocessable
iart-20190331_lab.xml	Edgar Link	unprocessable
iart-20190331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IART
Integra Lifesciences Holdings Corp Stock $iart

2019 Q1 Form 10-Q Financial Statement

#000091752019000021 Filed on April 29, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IART Integra Lifesciences Holdings Corp Stock $iart

2019 Q1 Form 10-Q Financial Statement

#000091752019000021 Filed on April 29, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IART
Integra Lifesciences Holdings Corp Stock $iart